Literature DB >> 18319008

KID syndrome.

Ali Abdollahi1, Zahra Hallaji, Nafiseh Esmaili, Mahin Valikhani, Masoumeh Barzegari, Maryam Akhyani, Siavash Toosi, Alireza Miresmaili.   

Abstract

KID syndrome is a rare congenital disorder characterized by keratitis, ichthyosis, and deafness. We have described a 4-year-old girl who is treated with bland emollients and topical keratolytics such as urea and surprisingly observed marked improvement in skin hyperkeratosis and palmoplantar keratoderma. We think that along with urgent ophthalmologic and otolaryngologic measures, simple topical therapies may improve skin condition in KID syndrome precluding the possible hazards of systemic retinoid therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18319008

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  4 in total

1.  Imaging Keratitis-Icthyosis-Deafness (KID) syndrome with FDG-PET (F18-fluorodeoxiglucose-Positron Emission Tomography).

Authors:  Carina Mari Aparici; Daniela Arcienega; Eric Cho; Randy Hawkins
Journal:  J Radiol Case Rep       Date:  2010-07-01

2.  Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases.

Authors:  Noah A Levit; Thomas W White
Journal:  Pharmacol Res       Date:  2015-07-23       Impact factor: 7.658

3.  The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome.

Authors:  Gulistan Mese; Caterina Sellitto; Leping Li; Hong-Zhan Wang; Virginijus Valiunas; Gabriele Richard; Peter R Brink; Thomas W White
Journal:  Mol Biol Cell       Date:  2011-10-26       Impact factor: 4.138

4.  Connexin hemichannel inhibition ameliorates epidermal pathology in a mouse model of keratitis ichthyosis deafness syndrome.

Authors:  Caterina Sellitto; Leping Li; Thomas W White
Journal:  Sci Rep       Date:  2021-12-16       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.